Skip to main content
PatentCliff

Stripe Patent Portfolio

20 US patents · Average 23 claims per patent

F
Patent Strength
34/100
20
Total Patents
23
Avg Claims
2
Expiring in 2 Years
3
Expiring in 5 Years

Technology Focus Areas

TelecommunicationsH04
20 patents
Computing & Data ProcessingG06
20 patents

Patent Details

Patent #TitleGrantedExpiresClaimsStatus
10004890Method for advanced wireless communication using cloudOct 2, 2027Dec 9, 2044518.7y left
10004891System for multi-layer neural network processing with edgeDec 21, 2006Sep 12, 20228Expired
10004892Method for enhanced channel estimation in photonic communicationsMay 3, 2024Sep 4, 20423316.4y left
10004893Method for modular wireless communication using analogJun 21, 2025May 19, 20421116.1y left
10004894Method for enhanced wireless communication using blockchainSep 1, 2026May 6, 20423516.1y left
10004895Method for advanced wireless communication using grapheneDec 8, 2022Nov 2, 2038712.6y left
10004896Method for distributed channel estimation in RF communicationsDec 25, 2010Feb 15, 2027450.9y left
10004897Method for advanced wireless communication using MEMSOct 1, 2008Mar 15, 202517Expired
10004898System for scalable signal transmission in photonic networksApr 23, 2022May 1, 20402814.1y left
10004899Apparatus for configurable data encoding in edge systemsMar 17, 2026May 1, 20443218.1y left
10004900Method for dynamic wireless communication using cloudJul 17, 2017Apr 22, 2034398.0y left
10004901Method for configurable wireless communication using neuralNov 11, 2003Apr 14, 202043Expired
10004902System for low-latency neural network processing with nano-scaleOct 25, 2025Dec 26, 20412215.7y left
10004903Method for high-performance channel estimation in blockchain communicationsFeb 20, 2025Oct 19, 20433517.5y left
10004904Apparatus for adaptive data encoding in CMOS systemsMay 12, 2023Aug 22, 20411615.4y left
10004905Method for integrated wireless communication using nano-scaleNov 19, 2003Sep 11, 202015Expired
10004906Computer-implemented method for efficient graphene optimizationMay 28, 2021Oct 12, 20394613.5y left
10004907Apparatus for autonomous data encoding in CMOS systemsMar 20, 2009Jan 18, 202610Expired
10004908Computer-implemented method for efficient CMOS optimizationSep 6, 2014Mar 2, 203154.9y left
10004909Method for adaptive channel estimation in 5G communicationsJul 7, 2009May 16, 2027111.1y left

Related Patent Portfolios

IBM

150 patents · Strength: B

Samsung

130 patents · Strength: C

Canon

90 patents · Strength: C

Microsoft

100 patents · Strength: C

Frequently Asked Questions

Stripe holds 20 US patents with an average of 23 claims per patent. The portfolio has a Patent Strength Score of 34/100 (Grade F).

Stripe has 2 patents expiring within 2 years and 3 patents expiring within 5 years. These expirations may create opportunities for competitors and generic entrants.

Stripe's key technology focus areas include Telecommunications, Computing & Data Processing. The portfolio spans 2 distinct technology classifications (CPC codes).

The Patent Strength Score (0-100, A-F) benchmarks a company's patent portfolio quality based on portfolio size (30%), claims breadth (25%), time remaining to expiration (25%), and portfolio diversity across technology areas (20%).

Last updated:

Patent Strength Score is based on portfolio size, claims breadth, time to expiration, and technology diversity using CPC classifications.

The this entity record above pulls directly from the FDA Orange Book and USPTO patent records. What follows is the per-entity context — how this entity sits in the broader U.S. pharmaceutical patent expirations distribution and which underlying factors drive the headline numbers.

Every number on this page links back to the FDA Orange Book and USPTO patent records; the methodology page describes the inputs, refresh cadence, and known limitations of the underlying data product.

For readers using this page as a decision input, the related-entity pages elsewhere on the site provide the comparison set. The most useful comparison for this entity is typically a peer within U.S. brand-name drugs with similar size, similar exposure, or similar geography — not the national-level summary alone.

Source: USPTO patent search, 2026.